Owens & Minor (OMI) Gets a Sell Rating from Barclays

Barclays analyst Steven Valiquette maintained a Sell rating on Owens & Minor (OMI) on January 4 and set a price target of $6. The company’s shares closed on Friday at $6.50, close to its 52-week low of $5.83.

According to TipRanks.com, Valiquette is a 4-star analyst with an average return of 4.1% and a 48.2% success rate. Valiquette covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, Patterson Companies Inc, and WellCare Health Plans.

The word on The Street in general, suggests a Hold analyst consensus rating for Owens & Minor with a $8.63 average price target.

See today’s analyst top recommended stocks >>

Based on Owens & Minor’s latest earnings release for the quarter ending September 30, the company reported a quarterly GAAP net loss of $565K. In comparison, last year the company had a net profit of $22.68 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Owens & Minor, Inc. engages in provision of services to the manufacturers of healthcare products, supplies, and devices. It operates through the following segments: Domestic, International, and Proprietary. The Domestic segment consists of U.S. distribution, logistics, and value-added services business.